The impact of human immunodeficiency virus on viral hepatitis

Liver International

Volumn 31, Issue SUPPL. 1, 2011, Pages 135-139

  Mallet, Vincent ^a   Vallet Pichard, Anaïs ^a   Pol, Stanislas ^a  

^a INSERM   (France)

Author keywords

Antiretroviral therapy; Co infection; HAART; HBV; HCC; HCV; Immune restoration; Natural history

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS E; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; LIVER HYPERPLASIA; LIVER TOXICITY; RISK REDUCTION; SUPERINFECTION; VACCINATION;

ADENINE; ANTIVIRAL AGENTS; DEOXYCYTIDINE; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; GUANINE; HEPATITIS B; HEPATITIS C; HEPATITIS VIRUSES; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; LAMIVUDINE; NUCLEOSIDES; PHOSPHONIC ACIDS; PYRIMIDINONES;

EID: 78650841124     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02394.x     Document Type: Article

References (12)

1. Salmon-Ceron D, Rosenthal E, Lewden C, et al. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: the French national mortalite 2005 study. J Hepatol 2009; 50: 736-45.
2. Thein HH, Yi Q, Dore GJ, Krahn MD. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 2008; 22: 1979-91.
3. Marcellin P, Pequignot F, Delarocque-Astagneau E, et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol 2008; 48: 200-7.
4. Berenguer J, Alvarez-Pellicer J, Martin PM, et al. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009; 50: 407-13.
5. Dionne-Odom J, Osborn MK, Radziewicz H, et al. Acute hepatitis C and HIV coinfection (abstract). Lancet Infect Dis 2009; 9: 775-83.
6. Pol S, Soriano V. Management of chronic hepatitis C virus infection in HIV-infected patients (abstract). Clin Infect Dis 2008; 47: 94-101.
7. Van den Eynde E, Tiraboschi JM, Tural C, et al. Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients (abstract). AIDS 2010; 24: 975-82.
8. Maylin S, Martinot-Peignoux M, Moucari R, et al. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology 2008; 135: 821-9.
9. Mallet V, Gilgenkrantz H, Serpaggi J, et al. Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C. Ann Intern Med 2008; 149: 399-3.
10. Cacoub P, Carrat F, Bedossa P, et al. Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 study. Antivir Ther 2009; 14: 839-45.
11. Piroth L, Sène D, Pol S, et al. Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY). AIDS 2007; 21: 1323-31.
12. Mallet VO, Dhalluin-Venier V, Verkarre V, et al. Reversibility of cirrhosis in HIV/HBV coinfection. Antivir Ther 2007; 12: 279-83.